14 Results for "

LRP5

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "LRP5" in MCE Product Catalog:

Cat. No.: HY-RS07800
Research Areas:  

Others

LRP5 Human Pre-designed siRNA Set A contains three designed siRNAs for LRP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24282
Research Areas:  

Others

Lrp5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lrp5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-125146
CAS No.: 301357-87-9
Purity:  99.21%
Target:  

Wnt

Research Areas:  

Others

BMD4503-2 is a quinoxaline derivative with inhibitory activity against LRP5/6-sclerostin interactions. BMD4503-2 restores the activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. BMD4503-2 can be used in the study of Wnt signaling pathways in bone development, maintenance and osteoporosis .
loading...
    loading...
Cat. No.: HY-RS16292
Research Areas:  

Cancer

Lrp5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lrp5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P992263

Target:  

Wnt

Research Areas:  

Inflammation/Immunology

Anti-LRP5 Antibody is a monoclonal antibody that targets LRP5. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-LRP5 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-169508
CAS No.: 301357-76-6
Target:  

Wnt

Research Areas:  

Others

BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6-Sclerostin interaction and regulate the Wnt signaling pathway .
loading...
    loading...
Cat. No.: HY-P991569

Target:  

Wnt

Research Areas:  

Metabolic Disease Endocrinology

PF-04840082 is a humanized IgG2 monoclonal antibody inhibitor targeting Dkk-1. PF-04840082 binds the physiological antagonist (Dkk-1) of the Wnt/LRP5 signal pathway and increases bone mass and bone mass density by activating osteoblasts. PF-04840082 can be used for osteoporosis research .
loading...
    loading...
Cat. No.: HY-E70390
Synonyms: masp-2, c1 esterase, c1-esterase
Target:  

Wnt

C1s Enzyme is a subunit of the complement C1 complex, which activates the complement as a serine protease. C1s Enzyme cleaves LRP5 and LRP6, and thus activates the Wnt/β-Catenin signaling pathway. C1s Enzyme promotes the macrophage M2 polarization and inhibits M1 polarization. C1s Enzyme enhances efferocytosis, exhibits anti-inflammatory activity .
loading...
    loading...
Cat. No.: HY-124841
CAS No.: 524-26-5
Synonyms: NCI8642
Target:  

Wnt β-catenin

Gallocyanine (NCI8642) is a DKK/LRP interaction inhibitor and Wnt/β-catenin signaling pathway activator. Gallocyanine binds to the YWTD repeat domains of LRP5/6, competitively blocks the interaction between DKK and LRP5/6, with an IC50 of approximately 3 μM for inhibiting DKK1 binding to LRP5, an IC50 of 6.38 μM for inhibiting DKK1 binding to LRP6, and a Ki of 14 μM for inhibiting the DKK2C/LRP6-E3E4 interaction. Gallocyanine reverses the inhibitory effect of DKK1 on WNT3A signaling, with an EC50 of approximately 5 μM. Gallocyanine can be used in studies related to Alzheimer's disease, bone formation and glucose metabolism .

loading...
    loading...
Cat. No.: HY-P78838
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LRP5; HBM; Prev. LRP7; Low Density Lipoprotein Receptor-Related Protein 5; Prev. EVR1; LRP-5; Prev. OPPG; LRP-7; LR3; Low Density Lipoprotein Receptor-Related Protein 7; Low-Density Lipoprotein Receptor-Related Protein 5; Low-Density Lipoprotein Receptor-
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P77989
Purity:  ≥ 90%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: LRP5; HBM; Prev. LRP7; Low Density Lipoprotein Receptor-Related Protein 5; Prev. EVR1; LRP-5; Prev. OPPG; LRP-7; LR3; Low Density Lipoprotein Receptor-Related Protein 7; Low-Density Lipoprotein Receptor-Related Protein 5; Low-Density Lipoprotein Receptor-
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P992126
CAS No.: 3059389-31-7
Synonyms: EYE-103; MK-3000

Target:  

Wnt

Research Areas:  

Neurological Disease

Remigromig (EYE-103; MK-3000) is a humanized dual-target monoclonal antibody that targets LRP5 and FZD4. Remigromig activates the Wnt/β-catenin signaling pathway by mimicking the natural ligand Norrin, induces tight junction formation and restores blood-retinal barrier function. Administered via intravitreal injection, Remigromig reduces retinal vascular leakage, and demonstrates improvements in best-corrected visual acuity and reductions in retinal thickness in studies of diabetic macular edema. Remigromig can be used for research related to macular degeneration .
loading...
    loading...
Cat. No.: HY-181930
CAS No.: 3112758-72-9
Target:  

Wnt c-Myc Apoptosis

Research Areas:  

Cancer

TNIK-IN-10 (Compound N15) is a TNIK inhibitor with an IC50 of 0.49 nM against human TNIK. TNIK-IN-10 inhibits the enzymatic activity of TNIK, downregulates the expression of Wnt pathway target genes c-Myc and AXIN2, and reduces the protein expression of LRP5 and LRP6. TNIK-IN-10 induces apoptosis. TNIK-IN-10 exhibits anticancer activity against colorectal cancer. TNIK-IN-10 can be used in the research of colorectal cancer .
loading...
    loading...
Cat. No.: HY-181585
CAS No.: 1403557-08-3
Target:  

Casein Kinase

Research Areas:  

Others

FP1-24 is a non-selective CK1 kinase inhibitor, with IC50 values of 40 nM, 10 nM, 10 nM, and 40 nM against human CK1γ1, CK1γ2, CK1γ3 and CK1δ, respectively. FP1-24 exerts its activity by reducing the phosphorylation level of LRP5/6 at the T1479 site during WNT signaling pathway activation. The non-specific binding of FP1-24 to multiple kinases can be used for biological studies of specific CK1γ .
loading...
    loading...
  • 1